Quest Partners LLC Tarsus Pharmaceuticals, Inc. Transaction History
Quest Partners LLC
- $1.02 Trillion
- Q2 2025
A detailed history of Quest Partners LLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 20,636 shares of TARS stock, worth $825,440. This represents 0.08% of its overall portfolio holdings.
Number of Shares
20,636
Previous 3,672
461.98%
Holding current value
$825,440
Previous $189 Million
343.17%
% of portfolio
0.08%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding TARS
# of Institutions
201Shares Held
44.1MCall Options Held
19.9KPut Options Held
7.6K-
Rtw Investments, LP New York, NY3.32MShares$133 Million2.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$131 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.61MShares$104 Million6.87% of portfolio
-
Jennison Associates LLC2.49MShares$99.7 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.45MShares$98.2 Million8.19% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.07B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...